These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9237520)

  • 41. Examining dopamine D3 receptor occupancy by antipsychotic drugs via [3H]7-OH-DPAT ex vivo autoradiography and its cross-validation via c-fos immunohistochemistry in the rat brain.
    Davoodi N; te Riele P; Langlois X
    Eur J Pharmacol; 2014 Oct; 740():669-75. PubMed ID: 24967534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Involvement of D1/D2 dopamine receptors within the nucleus accumbens and ventral tegmental area in the development of sensitization to antinociceptive effect of morphine.
    Reisi Z; Bani-Ardalan M; Zarepour L; Haghparast A
    Pharmacol Biochem Behav; 2014 Mar; 118():16-21. PubMed ID: 24418216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Imaging dopamine D4 receptors in the living primate brain: a positron emission tomography study using the novel D1/D4 antagonist [11C]SDZ GLC 756.
    Boy C; Klimke A; Holschbach M; Herzog H; Mühlensiepen H; Rota Kops E; Sonnenberg F; Gaebel W; Stöcklin G; Markstein R; Müller-Gärtner HW
    Synapse; 1998 Dec; 30(4):341-50. PubMed ID: 9826226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The rewarding effect of aggression is reduced by nucleus accumbens dopamine receptor antagonism in mice.
    Couppis MH; Kennedy CH
    Psychopharmacology (Berl); 2008 Apr; 197(3):449-56. PubMed ID: 18193405
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion.
    Neisewander JL; O'Dell LE; Redmond JC
    Brain Res; 1995 Feb; 671(2):201-12. PubMed ID: 7743209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inverse agonism at dopamine D2 receptors. Haloperidol-induced prolactin release from GH4C1 cells transfected with the human D2 receptor is antagonized by R(-)-n-propylnorapomorphine, raclopride, and phenoxybenzamine.
    Nilsson CL; Ekman A; Hellstrand M; Eriksson E
    Neuropsychopharmacology; 1996 Jul; 15(1):53-61. PubMed ID: 8797192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata.
    Ozer H; Ekinci AC; Starr MS
    Brain Res; 1997 Nov; 777(1-2):51-9. PubMed ID: 9449412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potency mismatch for behavioral and biochemical effects by dopamine receptor antagonists: implications for the mechanism of action of clozapine.
    Wadenberg ML; Ahlenius S; Svensson TH
    Psychopharmacology (Berl); 1993; 110(3):273-9. PubMed ID: 7831419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of the D(3) dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and food-restricted rats.
    Carr KD; Yamamoto N; Omura M; Cabeza de Vaca S; Krahne L
    Psychopharmacology (Berl); 2002 Aug; 163(1):76-84. PubMed ID: 12185403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of dopamine antagonists in a two-way active avoidance procedure in rats: interactions with 8-OH-DPAT, ritanserin, and prazosin.
    Prinssen EP; Kleven MS; Koek W
    Psychopharmacology (Berl); 1996 Nov; 128(2):191-7. PubMed ID: 8956380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period.
    Joyce JN
    Synapse; 2001 May; 40(2):137-44. PubMed ID: 11252025
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estradiol and striatal dopamine receptor antagonism influence memory system bias in the female rat.
    Quinlan MG; Almey A; Caissie M; LaChappelle I; Radiotis G; Brake WG
    Neurobiol Learn Mem; 2013 Nov; 106():221-9. PubMed ID: 24036396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduction of the rewarding effect of brain stimulation by a blockade of dopamine D1 receptor with SCH 23390.
    Nakajima S; McKenzie GM
    Pharmacol Biochem Behav; 1986 Apr; 24(4):919-23. PubMed ID: 3520603
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of dopamine receptors in the subthalamic nucleus of the rat: characterization using reverse transcriptase-polymerase chain reaction and autoradiography.
    Flores G; Liang JJ; Sierra A; Martínez-Fong D; Quirion R; Aceves J; Srivastava LK
    Neuroscience; 1999; 91(2):549-56. PubMed ID: 10366012
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626.
    Bowery BJ; Razzaque Z; Emms F; Patel S; Freedman S; Bristow L; Kulagowski J; Seabrook GR
    Br J Pharmacol; 1996 Dec; 119(7):1491-7. PubMed ID: 8968560
    [TBL] [Abstract][Full Text] [Related]  

  • 56. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
    Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms.
    Schetz JA; Chu A; Sibley DR
    J Pharmacol Exp Ther; 1999 May; 289(2):956-64. PubMed ID: 10215675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of D2 dopamine receptor blockade with raclopride on intracranial self-stimulation and food-reinforced operant behaviour.
    Nakajima S; Baker JD
    Psychopharmacology (Berl); 1989; 98(3):330-3. PubMed ID: 2501812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of l-stepholidine on forebrain Fos expression: comparison with clozapine and haloperidol.
    Mo YQ; Jin XL; Chen YT; Jin GZ; Shi WX
    Neuropsychopharmacology; 2005 Feb; 30(2):261-7. PubMed ID: 15578005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors.
    Tarazi FI; Yeghiayan SK; Baldessarini RJ; Kula NS; Neumeyer JL
    Neuropsychopharmacology; 1997 Sep; 17(3):186-96. PubMed ID: 9272485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.